WVE Wave Life Sciences Ltd. - Ordinary Shares
NASDAQ · Pharmaceuticals · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Lug 30, 2026
$3,78
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$3,56minimo 52 sett.
$20,63massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$731M
P/E
-14.0
EPS
$-1.21
Ricavi
$43M
i tuoi badge
Intervallo 52 sett.
$4–$21
Rating Analisti
BUY
Prezzo Obiettivo
$19
P/E
-14.0
ROE
·
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
WVE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$3.78
Capitalizzazione di Mercato (MRQ)
$731M
P/E
-14.0
EPS
$-1.21
Ricavi
$43M
Intervallo 52 sett.
$4–$21
WVE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Informazioni su Wave Life Sciences Ltd. - Ordinary Shares Panoramica della società da Wikipedia
settoreHealthcare
industriaPharmaceuticals
dipendenti317
paeseSG
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$43M2016-12-31 → 2025-12-31
EPS$-1.212021-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | WVE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -14.0media 5 anni ≈-9.2 | ≈-9.2 | · | · | |
| P/B (MRQ) | 1.6 | · | · | · | |
| Prezzo / FCF (TTM) | -3.8 | · | · | · | |
| Prezzo / Flusso di cassa (TTM) | -3.8 | · | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 6.2media 5 anni ≈9.0 | ≈9.0 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | WVE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 10.0 | · | · | · |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
| Metrica | Tendenza 5 anni | WVE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue YoY (Ricavi YoY) | -60.6%media 5 anni ≈590.6% | ≈590.6% | · | · | |
| Revenue CAGR 3Y (CAGR Ricavi 3Y) | 127.1%media 5 anni ≈81.1% | ≈81.1% | · | · | |
| Revenue CAGR 5Y (CAGR Ricavi 5Y) | 16.3% | · | · | · |
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | WVE | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue / Employee (Ricavi / Dipendente) | ≈$134.8K | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
3.3%
Prossimo report
Nov 09, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Lug 28, 2026 | $-0.34 | $-0.31 | -8.9% |
| 31 Marzo 2026 | Mag 7, 2026 | $-0.13 | $-0.33 | 60.7% |
| 31 Dicembre 2025 | $-0.30 | $-0.27 | -10.0% | |
| 30 Settembre 2025 | $-0.32 | $-0.30 | -6.2% | |
| 30 Giugno 2025 | $-0.31 | $-0.29 | -5.6% | |
| 31 Marzo 2025 | $-0.29 | $-0.26 | -10.1% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| R&D Expense | $183M | $160M | $130M | $116M | $122M | $131M | $175M | $134M | $79M | $41M | $9M | |
| SG&A Expense | $75M | $59M | $51M | $51M | $46M | $43M | $49M | $40M | $27M | $16M | $10M | |
| Operating Expenses | $258M | $219M | $181M | $166M | $168M | $173M | $224M | $174M | $106M | $57M | $19M | |
| Operating Income | $-215M | $-110M | $-68M | $-163M | $-127M | $-153M | $-208M | $-160M | $-102M | $-56M | $-19M | |
| Other Non-op | $527.0K | $3M | $2M | $7.0K | $5M | $2M | $10M | $10M | $-331.0K | $-50.0K | $56.0K | |
| Pretax Income | $-204M | $-97M | $-58M | $-161M | $-122M | $-151M | $-194M | $-147M | $-101M | $-55M | $-19M | |
| Income Tax | $0 | $0 | $-677.0K | $681.0K | $-204.0K | $-841.0K | $0 | $69.0K | $842.0K | $482.0K | $44.0K | |
| Net Income | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| EPS (Basic) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · | |
| Shares (Basic) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · | |
| Shares (Diluted) | 168,649,795 | 138,277,468 | 106,097,268 | 78,855,810 | 51,825,566 | · | · | · | · | · | · |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $602M | $302M | $200M | $88M | $151M | $184M | $147M | $175M | $143M | $150M | $161M | |
| Receivables | $1M | $1M | $21M | · | · | $30M | $20M | $10M | $1M | · | · | |
| Prepaid Expense | $8M | $10M | $10M | $8M | $7M | $10M | $10M | $7M | $7M | $1M | $146.0K | |
| Other Current Assets | $3M | $7M | $4M | $2M | $5M | $5M | $9M | $11M | · | · | · | |
| Current Assets | $615M | $320M | $235M | $99M | $163M | $230M | $185M | $202M | $150M | $152M | $161M | |
| PP&E (Net) | $7M | $10M | $13M | $17M | $22M | $29M | $36M | $40M | $27M | $9M | $3M | |
| PP&E (Gross) | $57M | $56M | $56M | $55M | $54M | $54M | $53M | $49M | $32M | $11M | $4M | |
| Accum. Depreciation | $50M | $46M | $43M | $38M | $32M | $25M | $17M | $10M | $4M | $2M | $2M | |
| Other Non-current Assets | $16.0K | $55.0K | $156.0K | · | · | · | · | · | · | · | · | |
| Total Assets | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Accounts Payable | $16M | $16M | $13M | $17M | $7M | $14M | $9M | $13M | $8M | $5M | $3M | |
| Accrued Liabilities | $7M | $5M | $2M | $4M | $4M | $2M | $5M | $6M | $3M | · | · | |
| Current Liabilities | $95M | $111M | $186M | $72M | $64M | $121M | $118M | $130M | $18M | $12M | $4M | |
| Capital Leases | $9M | $18M | $25M | $32M | $25M | $26M | $29M | · | · | $16.0K | $78.0K | |
| Other Non-current Liabilities | · | · | · | $190.0K | · | $474.0K | $2M | $2M | $2M | $796.0K | $163.0K | |
| Total Liabilities | $112M | $135M | $227M | $184M | $167M | $189M | $213M | $215M | $34M | $22M | $4M | |
| Common Stock | $1.62B | $1.18B | $935M | $803M | $750M | $694M | $540M | $375M | $310M | $216M | $185M | |
| Paid-in Capital | $228M | $156M | $129M | $119M | $88M | $72M | $57M | $38M | $22M | $10M | $3M | |
| Retained Earnings | $-1.33B | $-1.12B | $-1.02B | $-967M | $-806M | $-683M | $-533M | $-340M | $-193M | $-90M | $-35M | |
| AOCI | $-250.0K | $-262.0K | $-124.0K | $-29.0K | $181.0K | $389.0K | $267.0K | $153.0K | $116.0K | $-291.0K | $41.0K | |
| Stockholders' Equity | $518M | $210M | $40M | $-45M | $32M | $83M | $64M | $73M | $140M | $135M | $153M | |
| Liabilities + Equity | $638M | $352M | $275M | $146M | $207M | $279M | $284M | $296M | $182M | $165M | $165M | |
| Shares Outstanding | 187,660,263 | 153,037,286 | 119,162,234 | 86,924,643 | 59,841,116 | 48,778,678 | 34,340,690 | 29,472,197 | 27,829,079 | 23,502,169 | 21,551,423 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | $2M | $784.0K | $594.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | $4M | |
| Deferred Tax | $0 | $0 | $0 | · | · | · | · | · | $908.0K | $-698.0K | $36.0K | |
| Operating Cash Flow | $-187M | $-151M | $-19M | $-128M | $-89M | $-116M | $-188M | $-23M | $-84M | $-32M | $-13M | |
| CapEx | $718.0K | $938.0K | $1M | $1M | $560.0K | $1M | $4M | $10M | $19M | $6M | $2M | |
| Investing Cash Flow | $-718.0K | $-938.0K | $-1M | $-1M | $-560.0K | $-1M | $-4M | $-10M | $-19M | $-6M | · | |
| Stock Issued | · | · | $94M | $51M | · | $94M | $162M | $60M | $94M | $30M | $12M | |
| Financing Cash Flow | $488M | $254M | $133M | $67M | $56M | $155M | $164M | $65M | $94M | $29M | · | |
| Net Change in Cash | $300M | $102M | $112M | $-62M | $-34M | $37M | $-28M | $32M | $-8M | $-8M | $160M | |
| Taxes Paid | · | · | · | · | · | · | · | · | $-11.0K | $554.0K | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 | · | · | · | · | · | · |
Tassi di Crescita
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -60.6% | -4.4% | 3005.1% | -91.1% | 104.0% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 127.1% | 38.3% | 78.0% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 16.3% | · | · | · | · | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $43M | $108M | $113M | $4M | $41M | $20M | $16M | $14M | $4M | $1M | $152.0K | |
| Net Income TTM | $-204M | $-97M | $-58M | $-162M | $-122M | $-150M | $-194M | $-147M | $-102M | $-56M | $-19M | |
| P/E | -14.0 | -17.7 | -9.4 | -3.4 | -1.3 | · | · | · | · | · | · | |
| P / Tangible Book | 6.2 | 9.0 | 15.2 | · | 5.8 | 4.6 | · | · | · | · | · | |
| Earnings Yield | -7.1% | -5.7% | -10.7% | -29.3% | -75.2% | · | · | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $38M | · | · | $9M | $9M | · | · | $20M | $13M | $49M | $22M | $13M | $285.0K | $375.0K | $2M | |
| R&D Expense | $51M | $47M | $53M | $46M | $43M | $41M | $45M | $41M | $40M | $33M | $32M | $33M | $31M | $28M | $30M | $27M | |
| SG&A Expense | $25M | $22M | $21M | $18M | $18M | $18M | $16M | $15M | $14M | $14M | $13M | $12M | $12M | $12M | $13M | $12M | |
| Operating Expenses | $76M | $70M | $74M | $64M | $61M | $59M | $61M | $56M | $55M | $47M | $45M | $46M | $43M | $39M | $43M | $40M | |
| Operating Income | $-74M | $-31M | $-56M | $-56M | $-53M | $-50M | $23M | $-64M | $-35M | $-34M | $4M | $-23M | $-30M | $-39M | $-42M | $-38M | |
| Interest Income | $5M | $5M | · | $2M | $2M | $3M | · | $2M | $2M | $3M | · | · | · | · | · | · | |
| Other Non-op | $-275.0K | $-80.0K | $234.0K | $324.0K | $-82.0K | $51.0K | $3M | $337.0K | $-18.0K | $365.0K | $171.0K | $118.0K | $1M | $-701.0K | $744.0K | $254.0K | |
| Pretax Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-677.0K | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-69M | $-26M | $-53M | $-54M | $-50M | $-47M | $29M | $-62M | $-33M | $-32M | $7M | $-21M | $-27M | $-39M | $-41M | $-38M | |
| EPS (Basic) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| EPS (Diluted) | $-0.34 | $-0.13 | $-0.29 | $-0.32 | $-0.31 | $-0.29 | $0.26 | $-0.47 | $-0.25 | $-0.24 | $0.07 | $-0.20 | $-0.27 | $-0.42 | $-0.62 | $-0.62 | |
| Shares (Basic) | 204,008,712 | 200,167,869 | · | 167,739,208 | 163,987,640 | 162,572,026 | · | 132,563,467 | 129,527,003 | 129,271,678 | 106,025,063 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| Shares (Diluted) | 204,008,712 | 200,167,869 | · | 167,739,208 | 163,987,640 | 162,572,026 | · | 132,563,467 | 129,527,003 | 129,271,678 | 106,975,231 | 105,462,414 | 102,056,712 | 93,900,484 | 66,479,293 | 60,516,616 | |
| EBITDA | · | $-31M | · | $-56M | $-53M | $-50M | · | $-64M | $-35M | · | $4M | $-23M | $-30M | $-39M | $-42M | $-38M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $368M | $545M | $602M | $196M | $208M | $243M | $302M | $311M | $154M | $181M | $140M | $173M | $208M | $97M | $123M | $62M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | $25M | $25M | $50M | |
| Receivables | $888.0K | $0 | $1M | $10M | $2M | · | $1M | $0 | $1M | $0 | $7M | · | · | · | · | · | |
| Prepaid Expense | $12M | $13M | $8M | $7M | $7M | $8M | $10M | $11M | $12M | $11M | $8M | $9M | $9M | $7M | $5M | $7M | |
| Other Current Assets | $4M | $3M | $3M | $3M | $7M | $7M | $7M | $3M | $5M | $5M | $4M | $3M | $3M | $2M | $7M | $6M | |
| Current Assets | $508M | $561M | $615M | $215M | $224M | $258M | $320M | $325M | $172M | $197M | $159M | $185M | $220M | $131M | $160M | $124M | |
| PP&E (Net) | $7M | $7M | $7M | $8M | $9M | $10M | $10M | $11M | $12M | $12M | $14M | $15M | $16M | $19M | $20M | $21M | |
| PP&E (Gross) | · | · | $57M | · | · | · | $56M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $51M | $50M | $50M | $49M | $48M | $47M | $46M | $45M | $44M | $44M | $42M | $40M | $39M | · | · | · | |
| Other Non-current Assets | $667.0K | $386.0K | $16.0K | $22.0K | $728.0K | $448.0K | $55.0K | · | · | · | · | · | · | · | · | · | |
| Total Assets | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Accounts Payable | $20M | $19M | $16M | $14M | $15M | $14M | $16M | $13M | $18M | $12M | $13M | $12M | $12M | $16M | $11M | $10M | |
| Accrued Liabilities | $5M | $5M | $7M | $5M | $3M | $2M | $5M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | |
| Current Liabilities | $51M | $50M | $95M | $86M | $87M | $87M | $111M | $171M | $173M | $166M | $100M | $140M | $133M | $64M | $64M | $58M | |
| Capital Leases | $40M | $7M | $9M | $11M | $14M | $16M | $18M | $20M | $22M | $24M | $27M | $29M | $31M | $34M | $35M | $24M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $190.0K | $190.0K | · | · | $868.0K | |
| Total Liabilities | $105M | $72M | $112M | $109M | $105M | $109M | $135M | $209M | $204M | $202M | $233M | $274M | $294M | $178M | $174M | $160M | |
| Common Stock | $1.63B | $1.63B | $1.62B | $1.22B | $1.19B | $1.18B | $1.18B | $1.14B | $951M | $950M | $841M | $840M | $838M | $803M | $802M | $751M | |
| Paid-in Capital | $248M | $237M | $228M | $174M | $168M | $161M | $156M | $153M | $136M | $132M | $127M | $125M | $122M | $117M | $113M | $92M | |
| Retained Earnings | $-1.42B | $-1.35B | $-1.33B | $-1.27B | $-1.22B | $-1.17B | $-1.12B | $-1.15B | $-1.09B | $-1.06B | $-1.01B | $-1.02B | $-995M | $-924M | $-885M | $-843M | |
| AOCI | $-172.0K | $-254.0K | $-250.0K | $-190.0K | $-161.0K | $-204.0K | $-262.0K | $-159.0K | $-279.0K | $-198.0K | $-182.0K | $-150.0K | $-50.0K | $-123.0K | $-47.0K | $95.0K | |
| Stockholders' Equity | $454M | $512M | $518M | $125M | $139M | $172M | $210M | $142M | $-3M | $25M | $-40M | $-52M | $-35M | $-5M | $31M | $-53.0K | |
| Liabilities + Equity | $558M | $584M | $638M | $241M | $252M | $288M | $352M | $359M | $209M | $235M | $200M | $230M | $267M | $182M | $213M | $167M | |
| Shares Outstanding | 193,277,622 | 192,337,566 | 187,660,263 | 160,288,481 | 155,673,292 | 154,093,313 | 153,037,286 | 148,392,939 | 122,479,289 | 122,321,384 | 99,011,901 | 98,566,816 | 98,104,844 | 86,841,523 | 86,724,658 | 60,859,968 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-54M | $-60M | $-34M | $-45M | $-46M | $-63M | $-44M | $-46M | $-27M | $-33M | $-34M | $-37M | $86M | $-26M | $-29M | $-40M | |
| CapEx | $884.0K | $438.0K | $-1.0K | $248.0K | $306.0K | $165.0K | $86.0K | $383.0K | $52.0K | $417.0K | $198.0K | $72.0K | $489.0K | $457.0K | $492.0K | $208.0K | |
| Investing Cash Flow | $-123M | $-438.0K | $1.0K | $-248.0K | $-306.0K | $-165.0K | $-86.0K | $-383.0K | $-52.0K | $-417.0K | $-198.0K | $-72.0K | $-489.0K | $-501.0K | $25M | $-50M | |
| Stock Issued | · | · | · | · | · | · | · | $174M | $0 | $14M | $-35M | $-35M | $0 | $-229.0K | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $35M | · | · | · | |
| Financing Cash Flow | $330.0K | $3M | $440M | $33M | $12M | $4M | $35M | $204M | $653.0K | $15M | $2M | $2M | $35M | $17.0K | $66M | $1M | |
| Net Change in Cash | $-177M | $-57M | $406M | $-12M | $-35M | $-59M | $-9M | $157M | $-27M | $-19M | $-33M | $-36M | $120M | $-26M | $61M | $-89M | |
| Free Cash Flow | · | $-60M | · | · | · | $-63M | · | · | · | · | · | · | $85M | · | · | $-40M |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | · | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| Net Margin | · | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | · | 14.7% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| Pretax Margin | · | -68.2% | · | · | -580.2% | -510.9% | · | · | -167.2% | · | 13.4% | -95.5% | -212.0% | -13685.6% | -11012.3% | -2160.8% | |
| EBITDA Margin | · | -81.8% | · | · | -606.5% | -542.8% | · | · | -177.7% | · | 9.0% | -106.2% | -234.2% | -13648.8% | -11243.7% | -2176.8% | |
| ROA | · | -6.0% | · | -17.9% | -21.9% | -17.9% | · | -22.1% | -15.0% | · | 3.8% | -9.5% | -12.6% | -20.4% | -19.7% | -18.4% | |
| ROE | · | -7.6% | · | -40.5% | -74.3% | -47.5% | · | -122.2% | 119.3% | · | -32.2% | 203.2% | 157.7% | -307.3% | -156.5% | -143.3% | |
| ROIC | · | -6.1% | · | -45.2% | -37.9% | -29.0% | · | -45.1% | 1006.5% | · | -12.1% | 45.4% | 87.2% | 860.8% | -136.2% | 71875.5% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 11.3 | · | 2.5 | 2.6 | 3.0 | · | 1.9 | 1.0 | · | 1.6 | 1.3 | 1.7 | 2.0 | 2.5 | 2.1 | |
| Quick Ratio | · | 10.9 | · | 2.4 | 2.4 | 2.8 | · | 1.8 | 0.9 | · | 1.5 | 1.2 | 1.6 | 1.9 | 2.3 | 1.9 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | · | · | 0.0 | 0.0 | · | · | 0.1 | · | 0.3 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | 6.0 | · | · | · | 30.5 | · | 3.3 | · | · | · | · | · |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $2.66 | · | $0.78 | $0.89 | $1.11 | · | $0.95 | $-0.03 | · | $-0.41 | $-0.52 | $-0.35 | $-0.05 | $0.36 | $-0.00 | |
| Revenue / Share | · | $0.19 | · | · | $0.05 | $0.06 | · | · | $0.15 | · | $0.46 | $0.21 | $0.13 | $0.00 | $0.01 | · | |
| Cash Flow / Share | · | $-0.30 | · | · | · | $-0.39 | · | · | · | · | · | · | $0.84 | · | · | · | |
| Cash / Share | · | $2.83 | · | $1.22 | $1.34 | $1.58 | · | $2.10 | $1.26 | · | $1.41 | $1.75 | $2.12 | $1.12 | $1.42 | $1.01 | |
| EPS (TTM) | $-1.08 | $-1.05 | · | $-0.66 | $-0.81 | $-0.75 | · | $-1.10 | $-0.56 | $-0.51 | $-0.79 | $-1.28 | $-1.70 | $-2.27 | $-1.97 | $-2.13 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $110M | $110M | $113M | $85M | $37M | $15M | $4M | $40M | $43M | |
| Net Income TTM | $-202M | $-184M | · | $-122M | $-130M | $-112M | · | $-143M | $-73M | $-62M | $-85M | $-131M | $-151M | $-153M | $-120M | $-118M | |
| Market Cap | · | $1.39B | · | $1.17B | $1.01B | $1.25B | · | $1.22B | $611M | · | $569M | $359M | $425M | $313M | $282M | $122M | |
| P/E | -5.4 | -6.9 | · | -11.1 | -8.0 | -10.8 | · | -7.5 | -8.9 | -12.1 | -7.3 | -2.8 | -2.5 | -1.6 | -1.6 | -0.9 | |
| P/S | · | · | · | · | · | · | · | 11.0 | 5.5 | · | 6.7 | 9.8 | 28.6 | 75.1 | 7.0 | 2.8 | |
| P/B | · | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | -175.8 | · | -14.1 | -6.9 | -12.2 | -69.4 | 9.1 | -2296.6 | |
| P / Tangible Book | 2.5 | 2.7 | · | 9.4 | 7.3 | 7.2 | · | 8.6 | · | 29.7 | · | · | · | · | 9.1 | · | |
| P / Cash Flow | · | -23.4 | · | · | · | -19.8 | · | · | · | · | · | · | 5.0 | · | · | -3.1 | |
| Earnings Yield | -18.6% | -14.5% | · | -9.0% | -12.5% | -9.3% | · | -13.4% | -11.2% | -8.3% | -13.7% | -35.2% | -39.3% | -62.9% | -60.6% | -106.5% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $43M | $108M | $113M | $4M | $41M |
| Utile netto | $-204M | $-97M | $-58M | $-162M | $-122M |
| EPS Diluito | $-1.21 | $-0.70 | $-0.54 | $-2.05 | $-2.36 |
Nessun dato per questo bilancio
Dati fondamentali insufficienti per creare questo bilancio al momento.
Nessun dato per questo bilancio
Dati fondamentali insufficienti per creare questo bilancio al momento.
Proprietari istituzionali (13F) 261 filer · $1.1B totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
261
Valore detenuto
$1.1B
Nuove posizioni
50
Posizioni chiuse
39
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 50 (-7 vs trimestre precedente) | 39 (+3 vs trimestre precedente) | 99 (-14 vs trimestre precedente) | 59 (+5 vs trimestre precedente) | +5.4M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | $156.727.684 | 26.975.505 | 14,03% | Azioni |
| BlackRock, Inc. | $111.566.297 | 19.202.461 | 9,99% | Azioni |
| GSK plc | $106.007.465 | 18.245.691 | 9,49% | Azioni |
| VANGUARD GROUP INC | $60.753.682 | 3.573.746 | 5,44% | Azioni |
| MAVERICK CAPITAL LTD | $59.715.848 | 10.278.115 | 5,35% | Azioni |
| Driehaus Capital Management LLC | $31.624.661 | 5.443.143 | 2,83% | Azioni |
| PRIMECAP MANAGEMENT CO/CA/ | $31.110.354 | 5.354.622 | 2,79% | Azioni |
| 683 Capital Management, LLC | $28.759.500 | 4.950.000 | 2,57% | Azioni |
| FMR LLC | $28.599.589 | 4.922.477 | 2,56% | Azioni |
| STATE STREET CORP | $28.116.432 | 4.839.317 | 2,52% | Azioni |
| READYSTATE ASSET MANAGEMENT LP | $27.464.678 | 4.727.139 | 2,46% | Azioni |
| M28 Capital Management LP | $26.657.930 | 4.588.284 | 2,39% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $22.489.218 | 3.869.998 | 2,01% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $21.541.656 | 3.707.686 | 1,93% | Azioni |
| ALGERT GLOBAL LLC | $16.370.343 | 2.817.615 | 1,47% | Azioni |
| Qube Research & Technologies Ltd | $16.128.560 | 2.776.000 | 1,44% | Azioni |
| Squarepoint Ops LLC | $14.765.778 | 2.541.442 | 1,32% | Azioni |
| MORGAN STANLEY | $14.075.916 | 2.422.705 | 1,26% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.263.463 | 2.110.751 | 1,10% | Azioni |
| Pfizer Inc | $10.931.250 | 1.875.000 | 0,98% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $10.523.548 | 1.811.282 | 0,94% | Azioni |
| D. E. Shaw & Co., Inc. | $10.296.645 | 1.772.228 | 0,92% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.175.651 | 1.751.403 | 0,91% | Azioni |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $9.920.932 | 1.746.643 | 0,89% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $9.920.137 | 1.707.809 | 0,89% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $9.903.261 | 1.704.520 | 0,89% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $9.575.141 | 1.648.045 | 0,86% | Azioni |
| GOLDMAN SACHS GROUP INC | $9.425.807 | 1.622.342 | 0,84% | Azioni |
| Point72 Asset Management, L.P. | $8.627.786 | 1.484.989 | 0,77% | Azioni |
| FEDERATED HERMES, INC. | $8.518.820 | 1.466.234 | 0,76% | Azioni |
| RTW INVESTMENTS, LP | $7.843.500 | 1.350.000 | 0,70% | Azioni |
| NORTHERN TRUST CORP | $7.282.835 | 1.253.500 | 0,65% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.114.025 | 1.224.445 | 0,64% | Azioni |
| EMERALD ADVISERS, LLC | $7.111.237 | 1.223.965 | 0,64% | Azioni |
| MARSHALL WACE, LLP | $5.807.286 | 999.533 | 0,52% | Azioni |
| SymBiosis Capital Partners, LLC | $5.437.500 | 750.000 | 0,49% | Azioni |
| Pictet Asset Management Holding SA | $5.330.146 | 917.409 | 0,48% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $5.157.403 | 887.677 | 0,46% | Azioni |
| Aberdeen Group plc | $5.092.221 | 876.458 | 0,46% | Azioni |
| EMERALD MUTUAL FUND ADVISERS TRUST | $4.926.874 | 847.999 | 0,44% | Azioni |
| BAKER BROS. ADVISORS LP | $4.779.527 | 822.638 | 0,43% | Azioni |
| BNP PARIBAS FINANCIAL MARKETS | $4.712.241 | 811.057 | 0,42% | Azioni |
| CAPITAL FUND MANAGEMENT S.A. | $4.268.874 | 734.746 | 0,38% | Azioni |
| SPHERA FUNDS MANAGEMENT LTD. | $3.708.360 | 638.272 | 0,33% | Azioni |
| JPMORGAN CHASE & CO | $3.546.519 | 618.172 | 0,32% | Azioni |
| Y-Intercept (Hong Kong) Ltd | $3.544.646 | 610.094 | 0,32% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $3.533.607 | 608.194 | 0,32% | Azioni |
| TANG CAPITAL MANAGEMENT LLC | $3.486.000 | 600.000 | 0,31% | Azioni |
| Walleye Capital LLC | $3.401.482 | 585.453 | 0,30% | Azioni |
| Nuveen, LLC | $3.191.328 | 549.282 | 0,29% | Azioni |
Attivisti e proprietari del 5%+ 4 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×9 depositi | 11 Agosto 2026 | 16,80% | Modifica | · | SEC |
| Shin Nippon Biomedical Laboratories, Ltd., SNBL USA, Ltd., Ken Takanashi ×6 depositi | 12 Agosto 2022 | · | Deposito iniziale | · | SEC |
| Kagoshima Shinsangyo Sousei Investment Limited Partnership, Kagoshima Development Co. Ltd. ×5 depositi | 20 Luglio 2022 | · | Deposito iniziale | · | SEC |
| RA Capital Management, LLC, Peter Kolchinsky ×3 depositi | 28 Gennaio 2019 | · | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 22 insider · 8 dirigenti · 9 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Paul Bolno | President and CEO | 05 Febbraio 2026 A | 275.520 | 0 | 1 | $-140.956 |
| Kyle Moran | Chief Financial Officer | 05 Febbraio 2026 A | 134.385 | 0 | 7 | $-4.151.988 |
| David G Gaiero | Interim CFO | 03 Marzo 2020 A | 6.392 | 0 | 0 | $0 |
| Keith Regnante | Chief Financial Officer | 07 Marzo 2019 A | 29.186 | 0 | 0 | $0 |
| Chris Francis | SVP, Corporate Development, Head of Emerging Areas | 26 Febbraio 2026 M | 61.867 | 0 | 14 | $-7.103.233 |
| Chandra Vargeese | Chief Technology Officer, Head of Platform Discovery Sciences | 05 Febbraio 2026 A | 408.246 | 0 | 1 | $-43.417 |
| Michael A. Panzara | Chief Medical Officer, Head of Therapeutics Discovery and Development | 25 Luglio 2022 A | 109.103 | 0 | 0 | $0 |
| Mark Baldry | Chief Commerical Officer | 05 Agosto 2019 A | 39.000 | 0 | 0 | $0 |
| Gregory L. Verdine | Direttore | 08 Dicembre 2025 S | 275.217 | 0 | 2 | $-269.461 |
| Christian O Henry | Direttore | 08 Dicembre 2025 M | 12.700 | 0 | 4 | $-1.369.324 |
| Mark Corrigan | Direttore | 08 Dicembre 2025 S | 28.815 | 0 | 2 | $-217.265 |
| Amy Pott | Direttore | 18 Agosto 2020 A | · | 0 | 0 | $0 |
| Peter Kolchinsky | Direttore | 18 Agosto 2020 A | · | 0 | 0 | $0 |
| Koji Miura | Direttore | 15 Agosto 2019 A | · | 0 | 0 | $0 |
| Masaharu Tanaka | Direttore | 10 Novembre 2016 A | · | 0 | 0 | $0 |
| Takeshi Wada | Direttore | 10 Novembre 2016 A | · | 0 | 0 | $0 |
| GSK plc | Proprietario del 10% | 11 Dicembre 2025 P | 18.245.691 | 1 | 0 | $27.930.000 |
| Adrian Rawcliffe | · | 12 Agosto 2026 S | 0 | 0 | 3 | $-806.604 |
| Tan Aik Na | · | 11 Agosto 2026 S | 24.968 | 0 | 9 | $-1.825.754 |
| Ken Takanashi | · | 11 Agosto 2026 S | 20.079 | 0 | 1 | $-23.223 |
| Heidi L Wagner | · | 11 Agosto 2026 M | 44.930 | 0 | 3 | $-231.070 |
| Roberto Guerciolini | · | 07 Dicembre 2016 M | 4.000 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 30 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,11% | 41.500 NS | 31 Luglio 2026 | N-PORT |
| IHE · iShares Trust | 0,16% | 562.937 SH | 11 Settembre 2026 | Giornaliero |
| IWC · iShares Trust | 0,15% | 470.896 SH | 11 Settembre 2026 | Giornaliero |
| IBB · iShares Trust | 0,06% | 1.217.594 SH | 11 Settembre 2026 | Giornaliero |
| NUSC · Nushares ETF Trust | 0,05% | 122.389 NS | 31 Luglio 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,05% | 111.824 SH | 19 Agosto 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 13.788 SH | 01 Ottobre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,02% | 66.050 NS | 31 Luglio 2026 | N-PORT |
| IWM · iShares Trust | 0,02% | 3.532.850 SH | 11 Settembre 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 793.588 SH | 19 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,01% | 386.104 NS | 31 Luglio 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 88.704 SH | 01 Ottobre 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1.751.403 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,01% | 390.910 SH | 19 Agosto 2026 | Giornaliero |
| ISCG · iShares Trust | 0,01% | 14.841 SH | 11 Settembre 2026 | Giornaliero |
| WSML · iShares Trust | 0,01% | 7.302 SH | 11 Settembre 2026 | Giornaliero |
| DXUV · Dimensional ETF Trust | 0,00% | 4.263 NS | 31 Luglio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 19.243 NS | 31 Luglio 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 88.152 SH | 11 Settembre 2026 | Giornaliero |
| DFAC · Dimensional ETF Trust | 0,00% | 195.202 NS | 31 Luglio 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 64.397 SH | 10 Settembre 2026 | Giornaliero |
| DFSU · Dimensional ETF Trust | 0,00% | 6.250 NS | 31 Luglio 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 248.363 SH | 11 Settembre 2026 | Giornaliero |
| DFAU · Dimensional ETF Trust | 0,00% | 19.385 NS | 31 Luglio 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 33.180 NS | 31 Luglio 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 10.069 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11.431 SH | 19 Agosto 2026 | Giornaliero |
| IWN · iShares Trust | · | 1.201.565 SH | 11 Settembre 2026 | Giornaliero |
| ISCB · iShares Trust | · | 6.085 SH | 11 Settembre 2026 | Giornaliero |
| ISCV · iShares Trust | · | 18.901 SH | 11 Settembre 2026 | Giornaliero |
WVE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 21 analisti
COMPRA
Target mediano
$15.00
+296,8%
7 33,3%
Acquisto forte
13 61,9%
Compra
1 4,8%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
17 analisti · 2026-09-28Target medio $18.53 +390,2%
← Sotto tutti i target
Prezzo attuale $3.78
Basso$10.00
Media$18.53
Alto$42.00
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Lug 30, 2026